Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Nov 19, 2019 4:21pm

62 Views

Post# 30371167

BT - oddly, we agree on most of your points :)

BT:

Thank you for your considered comment and perspective.

The mantra is "Sell the News" and, yes, often share prices don't get too excited to the upside on a news release.

In Sernova's case, when it has released "Real News", the share price took off like the proverbial scalded cat on volume, but was beaten back on even more volume and mainly by Anonymous.

I do agree that either a terrific collaboration, or a Buy, Bye will be the only things that will eventually get shareholder's and the share price's real attention.